Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib

See also
Status	Clinical Trial	Phase
Completed	`NCT00492167` - Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma	Phase 1
Completed	`NCT04474678` - Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")	N/A
Terminated	`NCT00801931` - Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders	Phase 1/Phase 2
Active, not recruiting	`NCT03107988` - NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)	Phase 1
Recruiting	`NCT04253015` - A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta
Terminated	`NCT00788125` - Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors	Phase 1/Phase 2
Completed	`NCT03273712` - Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)	Phase 2
Recruiting	`NCT02933333` - G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor	Phase 4
Recruiting	`NCT00588068` - Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
Recruiting	`NCT04301843` - Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma	Phase 2
Completed	`NCT00026780` - Eligibility Screening for a NCI Pediatric Oncology Branch Research Study
Recruiting	`NCT04040088` - An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors	Early Phase 1
Recruiting	`NCT06057948` - A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma	Phase 2
Not yet recruiting	`NCT06335745` - PediCARE Health Equity Intervention in High-Risk Neuroblastoma	N/A
Recruiting	`NCT02559778` - Pediatric Precision Laboratory Advanced Neuroblastoma Therapy	Phase 2
Completed	`NCT02441062` - Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors	Phase 2
Active, not recruiting	`NCT02245997` - Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma	N/A
Not yet recruiting	`NCT01156350` - Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma	Phase 2
Active, not recruiting	`NCT01192555` - Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma	Phase 1/Phase 2
Completed	`NCT01222780` - To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer	Phase 1

NCT number	NCT04753658
Study type	Observational
Source	Pfizer
Contact
Status	Terminated
Phase
Start date	March 19, 2021
Completion date	September 30, 2022

Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms